Details
Original language | English |
---|---|
Publication status | Published - 21 Jul 2017 |
Event | International Conference of Numerical Analysis and Applied Mathematics 2016, ICNAAM 2016 - Rhodes, Rhodes, Greece Duration: 19 Sept 2016 → 25 Sept 2016 Conference number: 14, |
Conference
Conference | International Conference of Numerical Analysis and Applied Mathematics 2016, ICNAAM 2016 |
---|---|
Abbreviated title | ICNAAM 2016 |
Country/Territory | Greece |
City | Rhodes |
Period | 19 Sept 2016 → 25 Sept 2016 |
Abstract
Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
ASJC Scopus subject areas
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
2017. Paper presented at International Conference of Numerical Analysis and Applied Mathematics 2016, ICNAAM 2016, Rhodes, Greece.
Research output: Contribution to conference › Paper › Research › peer review
}
TY - CONF
T1 - Patentability aspects of computational cancer models
AU - Lishchuk, Iryna
N1 - Conference code: 14,
PY - 2017/7/21
Y1 - 2017/7/21
N2 - Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
AB - Multiscale cancer models, implemented in silico, simulate tumor progression at various spatial and temporal scales. Having the innovative substance and possessing the potential of being applied as decision support tools in clinical practice, patenting and obtaining patent rights in cancer models seems prima facie possible. What legal hurdles the cancer models need to overcome for being patented we inquire from this paper.
UR - http://www.scopus.com/inward/record.url?scp=85026637247&partnerID=8YFLogxK
U2 - 10.1063/1.4992197
DO - 10.1063/1.4992197
M3 - Paper
AN - SCOPUS:85026637247
T2 - International Conference of Numerical Analysis and Applied Mathematics 2016, ICNAAM 2016
Y2 - 19 September 2016 through 25 September 2016
ER -